Your browser doesn't support javascript.
loading
Transcription factor Tox2 is required for metabolic adaptation and tissue residency of ILC3 in the gut.
Das, Arundhoti; Martinez-Ruiz, Gustavo Ulises; Bouladoux, Nicolas; Stacy, Apollo; Moraly, Josquin; Vega-Sendino, Maria; Zhao, Yongge; Lavaert, Marieke; Ding, Yi; Morales-Sanchez, Abigail; Harly, Christelle; Seedhom, Mina O; Chari, Raj; Awasthi, Parirokh; Ikeuchi, Tomoko; Wang, Yueqiang; Zhu, Jinfang; Moutsopoulos, Niki M; Chen, WanJun; Yewdell, Jonathan W; Shapiro, Virginia Smith; Ruiz, Sergio; Taylor, Naomi; Belkaid, Yasmine; Bhandoola, Avinash.
Afiliación
  • Das A; Laboratory of Genome Integrity, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA.
  • Martinez-Ruiz GU; Laboratory of Genome Integrity, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA; Faculty of Medicine, Research Division, National Autonomous University of Mexico, Mexico City, Mexico; Children's Hospital of Mexico Federico Gomez, Mexico City, Mexico.
  • Bouladoux N; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, NIAID, NIH, Bethesda, MD, USA.
  • Stacy A; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, NIAID, NIH, Bethesda, MD, USA; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Moraly J; Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Vega-Sendino M; Laboratory of Genome Integrity, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA.
  • Zhao Y; Laboratory of Genome Integrity, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA.
  • Lavaert M; Laboratory of Genome Integrity, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA.
  • Ding Y; Laboratory of Genome Integrity, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA.
  • Morales-Sanchez A; Laboratory of Genome Integrity, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA; Children's Hospital of Mexico Federico Gomez, Mexico City, Mexico.
  • Harly C; Université de Nantes, CNRS, Inserm, CRCINA, Nantes, France; LabEx IGO "Immunotherapy, Graft, Oncology," Nantes, France.
  • Seedhom MO; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD, USA.
  • Chari R; Genome Modification Core, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Awasthi P; Mouse Modeling Core, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Ikeuchi T; Oral Immunity and Infection Section, NIDCR, NIH, Bethesda, MD, USA.
  • Wang Y; Shenzhen Typhoon HealthCare, Shenzhen, Guangdong, China.
  • Zhu J; Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Moutsopoulos NM; Oral Immunity and Infection Section, NIDCR, NIH, Bethesda, MD, USA.
  • Chen W; Mucosal Immunology Section, NIDCR, NIH, Bethesda, MD, USA.
  • Yewdell JW; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD, USA.
  • Shapiro VS; Department of Immunology, Mayo Clinic, Rochester, MN, USA.
  • Ruiz S; Laboratory of Genome Integrity, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA.
  • Taylor N; Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Belkaid Y; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, NIAID, NIH, Bethesda, MD, USA.
  • Bhandoola A; Laboratory of Genome Integrity, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA. Electronic address: avinash.bhandoola@nih.gov.
Immunity ; 57(5): 1019-1036.e9, 2024 May 14.
Article en En | MEDLINE | ID: mdl-38677292
ABSTRACT
Group 3 innate lymphoid cells (ILC3) are the major subset of gut-resident ILC with essential roles in infections and tissue repair, but how they adapt to the gut environment to maintain tissue residency is unclear. We report that Tox2 is critical for gut ILC3 maintenance and function. Gut ILC3 highly expressed Tox2, and depletion of Tox2 markedly decreased ILC3 in gut but not at central sites, resulting in defective control of Citrobacter rodentium infection. Single-cell transcriptional profiling revealed decreased expression of Hexokinase-2 in Tox2-deficient gut ILC3. Consistent with the requirement for hexokinases in glycolysis, Tox2-/- ILC3 displayed decreased ability to utilize glycolysis for protein translation. Ectopic expression of Hexokinase-2 rescued Tox2-/- gut ILC3 defects. Hypoxia and interleukin (IL)-17A each induced Tox2 expression in ILC3, suggesting a mechanism by which ILC3 adjusts to fluctuating environments by programming glycolytic metabolism. Our results reveal the requirement for Tox2 to support the metabolic adaptation of ILC3 within the gastrointestinal tract.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos / Ratones Noqueados / Proteínas HMGB / Citrobacter rodentium / Infecciones por Enterobacteriaceae / Glucólisis / Inmunidad Innata Límite: Animals Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos / Ratones Noqueados / Proteínas HMGB / Citrobacter rodentium / Infecciones por Enterobacteriaceae / Glucólisis / Inmunidad Innata Límite: Animals Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos